TG THERAPEUTICS, INC. (TGTX) Total liabilities 2016–2025
TG THERAPEUTICS, INC. (TGTX) total liabilities at each fiscal year-end, per SEC filings.
$415.2MFY2025 · since FY2016: $18.9M → $415.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $415.2M | +16.9% |
| FY2024 | $355.3M | +110.1% |
| FY2023 | $169.1M | +25.3% |
| FY2022 | $135.0M | -5.3% |
| FY2021 | $142.5M | +34.0% |
| FY2020 | $106.3M | -14.6% |
| FY2019 | $124.4M | +108.8% |
| FY2018 | $59.6M | +96.1% |
| FY2017 | $30.4M | +60.7% |
| FY2016 | $18.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice